Zentalis Pharmaceuticals Llc
Price & Volume
Stats
See more52W Range | $1.13-$6.95 |
Market Cap | $288.3M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $26.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $26.8M |
Diluted EPS | -$1.74 |
News
See moreYahoo Finance • 8 days ago
Zentalis To Present Part 1 Phase 1b MUIR Trial Results Of Azenosertib At ASCO 2026
Yahoo Finance • 9 days ago
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026
Yahoo Finance • 17 days ago
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance • 29 days ago
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Ms. Julie M. Eastland M.B.A. |
Address | 10275 Science Center Dr., San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 106 |